Target intelligence / Profile preview

Major pilin PilA (Nontypeable Haemophilus influenzae) (PilA)

Target
PilA
Molecular classification
Bacterial surface protein, Pilin family, Structural protein
01

Overview

Nontypeable Haemophilus influenzae (NTHi) PilA is the major structural subunit of the Type IV Pilus (T4P), a critical surface appendage used by the bacterium for host colonization and environmental adaptation. It plays a fundamental role in mediating adherence to the respiratory epithelium and is essential for the formation and structural integrity of bacterial biofilms, which protect NTHi from host immune clearance and antibiotic treatment. Beyond adhesion, PilA facilitates 'twitching motility'—a form of surface movement—and is involved in natural transformation by mediating the uptake of exogenous DNA. Because NTHi is a primary pathogen in pediatric otitis media and a major cause of exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD), PilA has emerged as a high-priority target for vaccine development. Current therapeutic strategies focus on generating antibodies against highly conserved regions of PilA to block bacterial attachment and disrupt biofilm-mediated persistence in the middle ear and lower airways.

Other names
Type IV pilin PilAMajor pilin subunitT4P major subunitPilA protein
02

Mechanism of action

Vaccine-induced antibodies bind to the PilA subunit to neutralize the function of Type IV pili, thereby preventing bacterial adherence to host respiratory epithelium and inhibiting the formation of protective biofilms.

03

Biological functions

Cell adhesionBacterial twitching motilityBiofilm formationDNA uptakeHorizontal gene transfer
04

Disease associations

Otitis mediaChronic obstructive pulmonary disease (COPD) exacerbationSinusitisBronchitisPneumonia
05

Safety considerations

Antigenic variation among different NTHi strainsPotential for immune evasion via structural polymorphismsRequirement for multi-component formulations to ensure broad serotype coverage
06

Interacting drugs

NTHi-002 (Investigational vaccine)

2 more in the full profile.

07

Biomarkers

Anti-PilA IgG antibody titersPilA-specific T-cell responseInhibition of twitching motility index

Beyond the preview

Go deeper on Major pilin PilA (Nontypeable Haemophilus influenzae) (PilA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major pilin PilA (Nontypeable Haemophilus influenzae) (PilA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call